Three weeks radiotherapy for T1 glottic cancer: The Christie and Royal Marsden Hospital Experience

Radiotherapy and Oncology

Volumn 68, Issue 2, 2003, Pages 105-111

  Gowda, Raghavendra V ^a   Henk, J Michael ^b   Mais, Kathleen L ^a   Sykes, Andrew J ^a   Swindell, Ric ^a   Slevin, Nicholas J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Fractionation; Laryngeal cancer; Radiotherapy; T1 glottic cancer

Indexed keywords

ADULT; AGED; ANTERIOR COMMISSURE; BRAIN METASTASIS; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL; HUMAN; INVASIVE CARCINOMA; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REVIEW; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; ARTICLE; CLINICAL TRIAL; GLOTTIS; LARYNX TUMOR; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 1542709651     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00059-8     Document Type: Article

References (54)

1. Akine Y., Tokita N., Ogino T., et al. Radiotherapy of T1 glottic cancer with 6MeV X-Rays. Int J Radiat Oncol Biol Phys. 20:1991;1215-1218.
2. Amornmarn R., Prempree T., Viravathana T., Donavanik V., Wizenberg M.J. A therapeutic approach to early vocal cord carcinoma. Acta Radiol Oncol. 24:1984;321-325.
3. Brenner D.J., Martinez A.A., Edmundson G.K., Mitchell C., Thames H.D., Armour E.P. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late responding normal tissue. Int J Radiat Oncol Biol Phys. 52:2002;6-13.
4. Cooper J.S., Pajak T.F., Rubin P., et al. Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys. 17:1989;449-456.
5. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
6. Duncan W., MacDougall R.H., Kerr G.R., et al. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol. 41:1996;203-207.
7. Epp E.R., Boyer A.L., Doppke K.P. Underdosing of lesions resulting from lack of electronic equilibrium in upper respiratory air cavity irradiated by 10MV X-ray beams. Int J Radiat Oncol Biol Phys. 2:1977;613-619.
8. Epstein B.E., Lee D.J., Kashima H., Johns M.E. Stage T1 glottic carcinoma: results of radiation therapy or laser excision. Radiology. 175:1990;567-570.
9. Fein D.A., Mendenhall W.M., Parsons J.T., et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: A multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys. 25:1993;605-611.
10. Fein D.A., Lee W.R., Hanlon A.L., et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinoma of the glottic larynx. J Clin Oncol. 13:1995;2077-2083.
11. Fein D.A., Lee W.R., Hanlon A.L., et al. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinoma of the glottic larynx? Int J Radiat Oncol Biol Phys. 1996;823-831.
12. Foote R.L., Grado G.L., Buskirk S.J., et al. Radiation therapy for glottic cancer using 6 MV photons. Cancer. 77:1996;381-386.
13. Fujita M., Rudoltz M.S., Canady D.J., et al. Second malignant neoplasia in patients with T1 glottic cancer treated with radiation. Laryngoscope. 108:1998;1853-1855.
14. Hansen O., Overgaard J., Hansen H.S., et al. Importance of overall time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiother Oncol. 43:1997;47-51.
15. Harwood A.R., Hawkins N.V., Rider W.D., et al. Radiotherapy of early glottic cancer-I. Int J Radiat Oncol Biol Phys. 5:1979;473-476.
16. Hayakawa K., Mitsuhashi N., Akimoto T., et al. The effect of overall treatment time of radiation therapy on local control of T1 stage squamous cell carcinoma of the glottis. Laryngoscope. 106:1996;1545-1547.
17. Izuno I., Sone S., Oguchi M., et al. Treatment of early vocal cord carcinoma with 60Co Gamma rays, 8/10 MV X-rays, or 4 MV X-rays- are the results different? Acta Oncol. 29:(5):1990;637-639.
18. Johansen L.V., Overgaard J., Hjelm-Hansen M., Gadberg C.C. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys. 18:1990;1307-1313.
19. Johansen L.V., Grau C., Overgaard J. Glottic carcinoma- patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol. 63:2002;257-267.
20. Kim R.Y., Mark M.E., Salter M.M. Early stage glottic cancer: Importance of dose fractionation in radiation therapy. Radiology. 182:1992;273-275.
21. Kirchner J.A. Cancer at the anterior commissure of the larynx: Results with radiotherapy. Arch Otolaryngol Head Neck Surg. 91:1970;524-525.
22. Le Q.T., Fu K.K., Kroll S., et al. Influence of fraction size, total dose and overall treatment time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 39:1997;115-126.
23. Lund C., Jorgensen K., Hjelm-Hansen M., Anderson A.P. Laryngeal carcinoma. III. Treatment results in relation to microscopic score. Acta Radiol Oncol. 18:1985;497-508.
24. Lustig R.A., MacLean C.T., Hanks G.E., et al. The pattern of care outcome studies: results of the national practice in carcinoma of the larynx. Int J Radiat Oncol Biol Phys. 10:1984;2357-2362.
25. Maheshwar A.A., Gaffney C.C. Radiotherapy for T1 glottic carcinoma: impact of anterior commissure involvement. J Laryngol Otol. 115:2001;298-301.
26. Mantravadi R.V.P., Liebner E.J., Haas R.E., Skolnik E.M., Applebaum E.L. Cancer of the glottis: prognostic factors in radiation therapy. Radiology. 149:1983;311-314.
27. Mendenhall W.M., Robert J.A., Christopher G.M., et al. T1-T2N0 Squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 19:2001;4029-4036.
28. Mendenhall W.M., Parsons J.T., Stringer S.P., Cassissi N.J. Management of Tis, T1 and T2 squamous cell carcinoma of the glottic larynx. Am J Otolaryngol. 4:1994;250-257.
29. Mendenhall W.M., Parsons J.T., Million R.R., et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys. 15:1988;1267-1273.
30. Million R.R. The larynx.... so to speak: everything I wanted to know about laryngeal cancer I learned in the past 32 years. Int J Radiat Oncol Biol Phys. 23:1992;691-704.
31. Moore C.J., Slevin N., Winstanley S., Woods H.A., Birzgallis A.R., Farrington W.T. Computerised quantification and 3D- visualisation of voice quality changes following radiotherapy for carcinoma of the larynx. Br Comp Soc, Proc. HC-99:1999;137-145.
32. Narayana A., Vaughan A.T., Fisher S.G., Reddy S.P. Second primary tumors in laryngeal cancer: results of long term follow up. Int J Radiat Oncol Biol Phys. 42:1998;557-562.
33. Nishimura Y., Nagata Y., Okajima K., et al. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control. Radiother Oncol. 40:1996;225-232.
34. Ogura J.H., Sessions D.G., Spector G.J. Analysis of surgical therapy for epidermoid carcinoma of the laryngeal glottis. Laryngoscope. 85:1975;1522-1530.
35. Olszewski S.J., Vaeth J.M., Green J.P., et al. The influence of field size, treatment modality, commissure involvement and histology in the treatment of early vocal cord cancer with irradiation. Int J Radiat Oncol Biol Phys. 11:1985;1333-1337.
36. O'Sullivan B., Warde P., Keane T., et al. Outcome following radiotherapy in verrucous carcinoma of the larynx. Int J Radiat Oncol Biol Phys. 32:1995;611-617.
37. Paterson R. Studies in optimum dosage. Br J Radiol. 25:1952;505-516.
38. Reddy S.P., Najeeb M., Marra S., et al. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. Radiother Oncol. 47:1998;161-166.
39. Roberts T.J., Epstein B., Lee D.J. Second neoplasms in patients with carcinomas of the vocal cord: incidence and implications for survival. Int J Radiat Oncol Biol Phys. 21:1991;583-589.
40. Robertson C., Robertson A.G., Hendry J.H., et al. Similar decreases in local control are calculated for treatment protraction and for interruptions in the radiotherapy on carcinoma of larynx in four centres. Int J Radiat Oncol Biol Phys. 40:1998;319-329.
41. Robertson A.G., Robertson C., Perone C., et al. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: A linear quadratic analysis. Radiother Oncol. 48:1998;165-173.
42. Rudoltz M.S., Benemmar A., Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys. 26:1993;767-772.
43. Schwaibold F., Scariato A., Nunno M., et al. The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys. 14:1988;451-454.
44. Slevin N.J., West C.M.L., Wilson G.D., Hendry J.H. The potential benefit from individualised radiotherapy scheduling for head and neck tumours on the basis of both histological grade and kinetics. Radiother Oncol. 51:1999;109-111.
45. 60Co versus 6MV photons. Head Neck. 18:1996;167-173.
46. Small W., Mital B.B., Brand W.N., et al. Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables. Radiology. 183:1992;789-794.
47. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol. 14:1993;116-121.
48. Teshima T., Chatani M., Inoue T. Radiation therapy for early glottic cancer (T1N0M0): II Prospective randomised study concerning radiation field. Int J Radiat Oncol Biol Phys. 18:1990;119-123.
49. Van der voet J.C.M., Keus R.B., Hart A.A.M., et al. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 42:1998;247-255.
50. Wang C.C. Treatment of glottic carcinoma by megavoltage radiation therapy and results. Am J Radiol. 120:1974;157-163.
51. Wang C.C., Efird J.T. Does prolonged treatment course adversely affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys. 29:1994;657-660.
52. Wiernik G., Alcock C.J., Bates T.D., et al. Final report on the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol. 64:1991;232.
53. Wilson G.D., McNally N.J., Dische S., et al. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer. 58:1988;423-431.
54. Yu E., Shenouda G., Beaudet M.P., et al. Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys. 37:1997;587-591.